PTK2 and neuroblastoma: ESK440 treatment in NB cell lines potently inhibits ALK and FAK phosphorylation and is associated with marked inhibition of signaling pathways such as AKT, ERK, and MYCN that have been implicated in NB growth (Fig. 2-3).